Yuchun Lee Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Yuchun Lee.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Yuchun Lee. Yuchun Lee is Director in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and President, CEO & Chairman in UNICA CORP ($UNCA) and President, CEO and Chairman in UNICA CORP ($UNCA).
Latest Insider Trading Transactions of Yuchun Lee
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2021 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | A | 217.20 | 6,067 | 1,317,752 | 6,067 | |
Jun 03 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | A | 286.27 | 4,527 | 1,295,944 | 4,527 | |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 1,125 | 64,429 | 0 | |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 261.80 | 116 | 30,369 | 1,875 | 2 K to 1.9 K (-5.83 %) |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 260.53 | 180 | 46,895 | 1,991 | 2.2 K to 2 K (-8.29 %) |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 259.61 | 120 | 31,153 | 2,171 | 2.3 K to 2.2 K (-5.24 %) |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 258.53 | 120 | 31,024 | 2,291 | 2.4 K to 2.3 K (-4.98 %) |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 257.20 | 149 | 38,323 | 2,411 | 2.6 K to 2.4 K (-5.82 %) |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 255.79 | 240 | 61,390 | 2,560 | 2.8 K to 2.6 K (-8.57 %) |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 254.81 | 200 | 50,962 | 2,800 | 3 K to 2.8 K (-6.67 %) |
Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 1,125 | 64,429 | 3,000 | 1.9 K to 3 K (+60.00 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 2,000 | 114,540 | 1,125 | |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 2,000 | 114,540 | 3,125 | |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 273.44 | 100 | 27,344 | 1,875 | 2 K to 1.9 K (-5.06 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 272.51 | 200 | 54,502 | 1,975 | 2.2 K to 2 K (-9.20 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 271.56 | 1,113 | 302,246 | 2,175 | 3.3 K to 2.2 K (-33.85 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 270.37 | 394 | 106,526 | 3,288 | 3.7 K to 3.3 K (-10.70 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 268.40 | 193 | 51,801 | 3,682 | 3.9 K to 3.7 K (-4.98 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 2,000 | 114,540 | 3,875 | 1.9 K to 3.9 K (+106.67 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 270.30 | 120 | 32,436 | 1,875 | 2 K to 1.9 K (-6.02 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 269.28 | 400 | 107,712 | 1,995 | 2.4 K to 2 K (-16.70 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 268.31 | 590 | 158,303 | 2,395 | 3 K to 2.4 K (-19.77 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 267.23 | 890 | 237,835 | 2,985 | 3.9 K to 3 K (-22.97 %) |
Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 2,000 | 114,540 | 3,875 | 1.9 K to 3.9 K (+106.67 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 2,000 | 114,540 | 5,125 | |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 2,000 | 114,540 | 7,125 | |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 276.45 | 47 | 12,993 | 1,875 | 1.9 K to 1.9 K (-2.45 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 275.90 | 600 | 165,540 | 1,922 | 2.5 K to 1.9 K (-23.79 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 274.23 | 400 | 109,692 | 2,522 | 2.9 K to 2.5 K (-13.69 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 272.55 | 100 | 27,255 | 2,922 | 3 K to 2.9 K (-3.31 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 271.03 | 300 | 81,309 | 3,022 | 3.3 K to 3 K (-9.03 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 269.23 | 200 | 53,846 | 3,322 | 3.5 K to 3.3 K (-5.68 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 267.47 | 353 | 94,417 | 3,522 | 3.9 K to 3.5 K (-9.11 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 2,000 | 114,540 | 3,875 | 1.9 K to 3.9 K (+106.67 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 270.54 | 369 | 99,829 | 1,875 | 2.2 K to 1.9 K (-16.44 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 269.47 | 300 | 80,841 | 2,244 | 2.5 K to 2.2 K (-11.79 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 268.48 | 224 | 60,140 | 2,544 | 2.8 K to 2.5 K (-8.09 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 267.34 | 507 | 135,541 | 2,768 | 3.3 K to 2.8 K (-15.48 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 266.18 | 300 | 79,854 | 3,275 | 3.6 K to 3.3 K (-8.39 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 265.16 | 300 | 79,548 | 3,575 | 3.9 K to 3.6 K (-7.74 %) |
Apr 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 2,000 | 114,540 | 3,875 | 1.9 K to 3.9 K (+106.67 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 2,000 | 114,540 | 9,125 | |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 2,000 | 114,540 | 11,125 | |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 272.63 | 100 | 27,263 | 1,875 | 2 K to 1.9 K (-5.06 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 271.38 | 300 | 81,414 | 1,975 | 2.3 K to 2 K (-13.19 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 268.50 | 100 | 26,850 | 2,275 | 2.4 K to 2.3 K (-4.21 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 267.15 | 403 | 107,661 | 2,375 | 2.8 K to 2.4 K (-14.51 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 265.88 | 300 | 79,764 | 2,778 | 3.1 K to 2.8 K (-9.75 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 264.80 | 500 | 132,400 | 3,078 | 3.6 K to 3.1 K (-13.97 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 263.20 | 297 | 78,170 | 3,578 | 3.9 K to 3.6 K (-7.66 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 2,000 | 114,540 | 3,875 | 1.9 K to 3.9 K (+106.67 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 274.65 | 500 | 137,325 | 1,875 | 2.4 K to 1.9 K (-21.05 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 273.61 | 890 | 243,513 | 2,375 | 3.3 K to 2.4 K (-27.26 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 271.52 | 510 | 138,475 | 3,265 | 3.8 K to 3.3 K (-13.51 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 269.97 | 100 | 26,997 | 3,775 | 3.9 K to 3.8 K (-2.58 %) |
Apr 22 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 2,000 | 114,540 | 3,875 | 1.9 K to 3.9 K (+106.67 %) |
Feb 11 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 2,000 | 114,540 | 14,306 | |
Feb 11 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 239.96 | 600 | 143,976 | 1,875 | 2.5 K to 1.9 K (-24.24 %) |
Feb 11 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 238.50 | 200 | 47,700 | 2,475 | 2.7 K to 2.5 K (-7.48 %) |
Feb 11 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 237.51 | 700 | 166,257 | 2,675 | 3.4 K to 2.7 K (-20.74 %) |
Feb 11 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 236.29 | 200 | 47,258 | 3,375 | 3.6 K to 3.4 K (-5.59 %) |
Feb 11 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 234.84 | 300 | 70,452 | 3,575 | 3.9 K to 3.6 K (-7.74 %) |
Feb 11 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 2,000 | 114,540 | 3,875 | 1.9 K to 3.9 K (+106.67 %) |
Feb 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 2,000 | 114,540 | 18,306 | |
Feb 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 3,028 | 173,414 | 20,306 | |
Feb 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 243.78 | 332 | 80,935 | 1,875 | 2.2 K to 1.9 K (-15.04 %) |
Feb 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 243.13 | 637 | 154,874 | 2,207 | 2.8 K to 2.2 K (-22.40 %) |
Feb 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 242.03 | 629 | 152,237 | 2,844 | 3.5 K to 2.8 K (-18.11 %) |
Feb 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 240.59 | 402 | 96,717 | 3,473 | 3.9 K to 3.5 K (-10.37 %) |
Feb 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 2,000 | 114,540 | 3,875 | 1.9 K to 3.9 K (+106.67 %) |
Feb 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 241.01 | 112 | 26,993 | 1,875 | 2 K to 1.9 K (-5.64 %) |
Feb 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 239.81 | 1,026 | 246,045 | 1,987 | 3 K to 2 K (-34.05 %) |
Feb 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 238.94 | 353 | 84,346 | 3,013 | 3.4 K to 3 K (-10.49 %) |
Feb 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 236.99 | 233 | 55,219 | 3,366 | 3.6 K to 3.4 K (-6.47 %) |
Feb 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 236.19 | 161 | 38,027 | 3,599 | 3.8 K to 3.6 K (-4.28 %) |
Feb 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 235.15 | 115 | 27,042 | 3,760 | 3.9 K to 3.8 K (-2.97 %) |
Feb 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 3,028 | 173,414 | 3,875 | 847 to 3.9 K (+357.50 %) |
Feb 04 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 232.69 | 200 | 46,538 | 847 | 1 K to 847 (-19.10 %) |
Feb 04 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 231.70 | 956 | 221,505 | 1,047 | 2 K to 1 K (-47.73 %) |
Feb 04 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 230.69 | 421 | 97,120 | 2,003 | 2.4 K to 2 K (-17.37 %) |
Feb 04 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 229.39 | 423 | 97,032 | 2,424 | 2.8 K to 2.4 K (-14.86 %) |
Feb 04 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 233.37 | 200 | 46,674 | 2,847 | 3 K to 2.8 K (-6.56 %) |
Feb 04 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 232.51 | 300 | 69,753 | 3,047 | 3.3 K to 3 K (-8.96 %) |
Feb 04 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 230.04 | 100 | 23,004 | 3,347 | 3.4 K to 3.3 K (-2.90 %) |
Feb 04 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 227.54 | 171 | 38,909 | 3,447 | 3.6 K to 3.4 K (-4.73 %) |
Feb 04 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 226.64 | 823 | 186,525 | 3,618 | 4.4 K to 3.6 K (-18.53 %) |
Feb 04 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 225.10 | 206 | 46,371 | 4,441 | 4.6 K to 4.4 K (-4.43 %) |
Feb 04 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 224.03 | 200 | 44,806 | 4,647 | 4.8 K to 4.6 K (-4.13 %) |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | A | 152.74 | 3,229 | 493,197 | 3,229 | |
Jun 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Grant | A | 0.00 | 1,801 | 0 | 6,648 | 4.8 K to 6.6 K (+37.16 %) |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 125.71 | 5,295 | 665,634 | 5,295 | |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 128.44 | 1,323 | 169,926 | 4,847 | 6.2 K to 4.8 K (-21.44 %) |
Jun 05 2017 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Grant | A | 0.00 | 2,188 | 0 | 6,170 | 4 K to 6.2 K (+54.95 %) |
Jun 03 2016 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | A | 93.51 | 7,073 | 661,396 | 7,073 | |
Jun 03 2016 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Grant | A | 0.01 | 2,941 | 29 | 3,982 | 1 K to 4 K (+282.52 %) |
Jan 06 2016 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 1,333 | 76,341 | 23,334 | |
Jan 06 2016 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 122.87 | 200 | 24,574 | 1,041 | 1.2 K to 1 K (-16.12 %) |
Jan 06 2016 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 122.07 | 925 | 112,915 | 1,241 | 2.2 K to 1.2 K (-42.71 %) |
Jan 06 2016 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 1,333 | 76,341 | 2,166 | 833 to 2.2 K (+160.02 %) |
Dec 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 1,333 | 76,341 | 24,667 | |
Dec 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 131.21 | 100 | 13,121 | 833 | 933 to 833 (-10.72 %) |
Dec 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 129.97 | 625 | 81,231 | 933 | 1.6 K to 933 (-40.12 %) |
Dec 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 128.77 | 400 | 51,508 | 1,558 | 2 K to 1.6 K (-20.43 %) |
Dec 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 1,333 | 76,341 | 1,958 | 625 to 2 K (+213.28 %) |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 1,334 | 76,398 | 26,000 | |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 126.98 | 500 | 63,490 | 625 | 1.1 K to 625 (-44.44 %) |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 125.93 | 525 | 66,113 | 1,125 | 1.7 K to 1.1 K (-31.82 %) |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 123.64 | 100 | 12,364 | 1,650 | 1.8 K to 1.7 K (-5.71 %) |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 1,334 | 76,398 | 1,750 | 416 to 1.8 K (+320.67 %) |
Oct 05 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 1,333 | 76,341 | 27,334 | |
Oct 05 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 105.79 | 225 | 23,803 | 416 | 641 to 416 (-35.10 %) |
Oct 05 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 104.79 | 700 | 73,353 | 641 | 1.3 K to 641 (-52.20 %) |
Oct 05 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 102.80 | 200 | 20,560 | 1,341 | 1.5 K to 1.3 K (-12.98 %) |
Oct 05 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 1,333 | 76,341 | 1,541 | 208 to 1.5 K (+640.87 %) |
Sep 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | A | 57.27 | 1,333 | 76,341 | 28,667 | |
Sep 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 126.32 | 200 | 25,264 | 208 | 408 to 208 (-49.02 %) |
Sep 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 125.35 | 825 | 103,414 | 408 | 1.2 K to 408 (-66.91 %) |
Sep 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 123.92 | 100 | 12,392 | 1,233 | 1.3 K to 1.2 K (-7.50 %) |
Sep 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 1,333 | 76,341 | 1,333 | 0 to 1.3 K |
Jun 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | A | 127.54 | 20,000 | 2,550,800 | 20,000 | |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Option Exercise | D | 6.79 | 50,000 | 339,500 | 0 | |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Option Exercise | D | 4.21 | 50,000 | 210,500 | 0 | |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Option Exercise | D | 6.46 | 60,000 | 387,600 | 0 | |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Option Exercise | D | 11.40 | 40,000 | 456,000 | 0 | |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Option Exercise | D | 3.00 | 61,666 | 184,998 | 0 | |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Option Exercise | D | 3.00 | 185,000 | 555,000 | 0 | |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Option Exercise | M | 3.30 | 33,333 | 109,999 | 0 | |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Option Exercise | D | 0.00 | 50,000 | 0 | 0 | |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Option Exercise | D | 0.00 | 37,500 | 0 | 0 | |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Option Exercise | D | 0.00 | 5,000 | 0 | 0 | |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | D | 21.00 | 166,913 | 3,505,173 | 0 | 166.9 K to 0 (-100.00 %) |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | D | 21.00 | 300,890 | 6,318,690 | 0 | 300.9 K to 0 (-100.00 %) |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | D | 21.00 | 686,616 | 14,418,936 | 0 | 686.6 K to 0 (-100.00 %) |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | D | 21.00 | 1,000,000 | 21,000,000 | 0 | 1000 K to 0 (-100.00 %) |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | D | 21.00 | 2,192,197 | 46,036,137 | 0 | 2.2 M to 0 (-100.00 %) |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | D | 21.00 | 14,142 | 296,982 | 0 | 14.1 K to 0 (-100.00 %) |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | D | 21.00 | 52,104 | 1,094,184 | 0 | 52.1 K to 0 (-100.00 %) |
Oct 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Buy | M | 3.30 | 33,333 | 109,999 | 52,104 | 18.8 K to 52.1 K (+177.58 %) |
Jun 09 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | S | 9.55 | 7,351 | 70,213 | 1,998,614 | 2 M to 2 M (-0.37 %) |
Jun 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | S | 9.58 | 12,100 | 115,877 | 2,005,965 | 2 M to 2 M (-0.60 %) |
Jun 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | S | 9.86 | 6,077 | 59,938 | 2,018,065 | 2 M to 2 M (-0.30 %) |
Jun 07 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | S | 10.16 | 7,260 | 73,758 | 2,024,142 | 2 M to 2 M (-0.36 %) |
Jun 02 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | S | 10.04 | 11,500 | 115,415 | 2,031,402 | 2 M to 2 M (-0.56 %) |
Jun 02 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | S | 10.10 | 5,712 | 57,672 | 2,042,902 | 2 M to 2 M (-0.28 %) |
May 14 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | S | 10.31 | 18,400 | 189,768 | 2,048,614 | 2.1 M to 2 M (-0.89 %) |
May 14 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | S | 10.07 | 16,500 | 166,180 | 2,067,014 | 2.1 M to 2.1 M (-0.79 %) |
May 12 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | S | 9.87 | 7,000 | 69,094 | 2,083,514 | 2.1 M to 2.1 M (-0.33 %) |
May 12 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Sell | S | 9.83 | 8,100 | 79,583 | 2,090,514 | 2.1 M to 2.1 M (-0.39 %) |
Mar 10 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Option Exercise | M | 3.88 | 150 | 582 | 75 | |
Mar 10 2010 | UNCA | UNICA CORP | Lee Yuchun | President, CEO & Ch ... | Option Exercise | M | 6.46 | 375 | 2,423 | 62 |